Profile data is unavailable for this security.
About the company
Ansell Limited is an Australia-based company offering safety solutions. The Company is an integrated manufacturer of personal protection equipment for healthcare and industrial workplaces. Its brands such as HyFlex, Ringers, MICROFLEX, TouchNTuff, GAMMEX, and AlphaTec. The Company is engaged in designing, developing, and manufacturing a range of hand, arm and body protection solutions and clothing. The Company operates through two segments: Healthcare Global Business Unit (GBU), and Industrial GBU. The Healthcare GBU segment is consists of surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single use industrial application gloves. The Industrial GBU segment comprises multi-use hand and body protection solutions for industrial worker environments and specialty applications. The Company operates other brands consists of the Kimtech, KleenGuard, The RightCycle Program, and APEX.
- Revenue in AUD (TTM)2.42bn
- Net income in AUD114.55m
- Incorporated1920
- Employees15.95k
- LocationAnsell LtdLevel 3, 678 Victoria StRICHMOND 3121AustraliaAUS
- Phone+61 39270-7270
- Fax+61 39270-7300
- Websitehttps://www.ansell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NIHON KOHDEN CORPORATION | 2.20bn | 94.46m | 3.79bn | 5.89k | 39.09 | 2.11 | 28.05 | 1.72 | 57.04 | 57.04 | 1,321.40 | 1,058.57 | 1.01 | 1.87 | 3.87 | 37,554,580.00 | 4.32 | 8.66 | 5.34 | 11.40 | 50.29 | 50.85 | 4.29 | 8.41 | 2.79 | -- | 0.0027 | 27.52 | 7.45 | 4.42 | -0.4909 | 8.75 | 8.05 | 11.75 |
| Hartalega Holdings Berhad | 686.97m | 33.59m | 3.91bn | 9.04k | 116.01 | 2.40 | 47.68 | 5.69 | 0.0284 | 0.0284 | 0.5803 | 1.37 | 0.3768 | -- | 9.35 | 219,237.90 | 1.96 | 24.51 | 2.10 | 28.28 | -- | 46.45 | 5.19 | 29.23 | 4.80 | 19.75 | 0.0097 | 45.57 | -23.72 | -8.25 | 105.32 | -51.27 | -17.35 | -46.78 |
| Eyebright Medical Tchnlgy Beijing Co Ltd | 287.42m | 78.21m | 4.05bn | 2.07k | 51.71 | 8.21 | -- | 14.09 | 1.95 | 1.95 | 7.17 | 12.29 | 0.4599 | 2.40 | 4.64 | 654,939.80 | 11.73 | 9.99 | 13.29 | 11.16 | 65.58 | 81.29 | 25.50 | 34.66 | 3.76 | 41.18 | 0.1904 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
| Alfresa Holdings Corporation | 28.73bn | 316.20m | 4.41bn | 12.52k | 12.85 | 0.831 | 9.70 | 0.1535 | 169.96 | 169.96 | 15,444.13 | 2,628.07 | 2.00 | 16.85 | 4.37 | 230,646,200.00 | 2.17 | 2.27 | 6.01 | 5.93 | 7.26 | 7.25 | 1.09 | 1.13 | 1.05 | -- | 0.0576 | 37.85 | 6.02 | 1.60 | 14.63 | -6.66 | 2.32 | 7.39 |
| QuantumPharm Inc | 41.90m | -539.68m | 4.44bn | 760.00 | -- | 5.06 | -- | 105.85 | -1.08 | -1.08 | 0.1037 | 1.31 | -- | -- | -- | 273,886.60 | -- | -- | -- | -- | -- | -- | -1,280.46 | -- | -- | -- | 0.038 | -- | 30.80 | -- | -33.08 | -- | -- | -- |
| MGI Tech Co Ltd | 545.18m | -184.74m | 4.49bn | 2.87k | -- | 2.65 | -- | 8.23 | -2.12 | -2.12 | 6.26 | 19.21 | 0.2467 | 0.7745 | 2.87 | 898,663.20 | -8.40 | -- | -9.62 | -- | 59.99 | -- | -34.04 | -- | 3.99 | -- | 0.0766 | -- | -31.19 | -- | -129.98 | -- | -- | -- |
| Shandong Weigao Group Medical Polymer Co | 2.76bn | 406.44m | 4.49bn | 12.61k | 10.92 | 0.9156 | 7.28 | 1.63 | 0.4605 | 0.4605 | 3.12 | 5.49 | 0.3787 | 2.81 | 2.05 | 1,127,114.00 | 5.76 | 7.89 | 7.47 | 10.08 | 49.94 | 55.03 | 15.21 | 18.65 | 2.89 | 12.31 | 0.1436 | 30.03 | -3.77 | 8.47 | -27.57 | 6.33 | -2.93 | 10.76 |
| Ansell Ltd | 2.42bn | 114.55m | 4.75bn | 15.95k | 37.23 | 1.67 | 21.13 | 1.96 | 0.8741 | 0.8741 | 18.74 | 19.53 | 0.561 | 2.02 | 8.03 | 152,016.80 | 2.68 | 6.11 | 3.16 | 7.33 | 38.58 | 37.78 | 4.79 | 8.97 | 2.75 | 15.07 | 0.3098 | 43.55 | -2.16 | 1.56 | -48.42 | -7.29 | 7.57 | -4.12 |
| Poly Medicure Ltd. | 274.02m | 53.07m | 5.07bn | 2.65k | 90.83 | 10.87 | 76.62 | 18.51 | 30.62 | 30.62 | 158.16 | 255.82 | 0.6411 | 2.11 | 5.24 | 5,742,980.00 | 12.42 | 13.16 | 14.70 | 16.12 | 66.50 | 55.62 | 19.37 | 16.69 | 3.97 | 30.38 | 0.0584 | 15.10 | 23.36 | 17.63 | 44.05 | 31.61 | 28.85 | 8.45 |
| Autobio Diagnostics Co Ltd | 969.38m | 269.30m | 5.68bn | 5.54k | 21.05 | 3.19 | -- | 5.86 | 2.19 | 2.19 | 7.90 | 14.46 | 0.4079 | 1.91 | 3.93 | 827,079.50 | 11.38 | 12.59 | 14.54 | 15.79 | 64.93 | 61.62 | 27.90 | 26.96 | 2.18 | -- | 0.1093 | 46.40 | 0.0457 | 18.15 | 4.28 | 16.70 | 17.03 | 11.32 |
| Holder | Shares | % Held |
|---|---|---|
| Allan Gray (Pty) Ltd.as of 19 Jul 2024 | 23.89m | 16.37% |
| Australian Retirement Trust Pty Ltd.as of 20 Sep 2024 | 7.38m | 5.06% |
| The Vanguard Group, Inc.as of 29 Dec 2023 | 6.67m | 4.57% |
| State Street Global Advisors, Australia, Ltd.as of 19 Jul 2024 | 6.64m | 4.55% |
| Allan Gray Australia Pty Ltd.as of 30 Jun 2024 | 6.58m | 4.51% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 4.53m | 3.10% |
| Vanguard Investments Australia Ltd.as of 30 Sep 2024 | 2.65m | 1.81% |
| Commonwealth Superannuation Corp. (Investment Management)as of 25 Jul 2024 | 1.83m | 1.26% |
| Harris Associates LPas of 30 Sep 2024 | 1.79m | 1.23% |
| BlackRock Fund Advisorsas of 02 Oct 2024 | 1.71m | 1.17% |
